Skip to content

Biomedical Sciences (PhD)

Neuroscience, Cell Biology and Physiology, Cancer and Developmental Biology, Molecular and Systems Pharmacology, Microbiology-Immunology-Biochemistry

The Biomedical Sciences Program (aka Integrated Biomedical Sciences (IBS)) is a research-oriented graduate program that involves faculty from UTHSC and affiliate faculty from nearby St. Jude Children’s Research Hospital and the Veterans Affairs Medical Center. Students apply directly to the IBS Program, but choose among six research tracks: Cancer and Developmental Biology; Cell Biology and Physiology; Genetics, Genomics and Informatics; Microbiology, Immunology, and Biochemistry; Molecular and Systems Pharmacology; and Neuroscience.

Students in the IBS Program choose from a menu of courses to fulfill core and elective curricular requirements, a process that allows them to tailor their curriculum to their educational and research needs. Course selection is only one of several flexible features of the IBS Program designed to enable students to gain an edge in today’s competitive research environment. Most students choose to identify a research track before enrolling in the IBS Program, while others may consider more than one track, and are free to switch tracks during their first year. All students participate in laboratory rotations before selecting a research mentor, allowing the student to thoroughly explore their dissertation research options. The world class research environment at UTHSC and St. Jude along with the flexibility of the program and an extremely high faculty to student ratio make the UTHSC Integrated Biomedical Sciences Program ideal for the student looking for a personalized, highpowered PhD program that will launch them into a top notch biomedical sciences career.

Requirements: Bachelor degree with a grade-point average of at least 3.0 from an accredited college or university, a combined score (verbal and quantitative) of at least 300 on the revised Graduate Record Examination, a score of at least 213/79 on the computer-based/Internet-based TOEFL or evidence of proficiency in English for students whose native language is not English, and three letters of recommendation.

Priority deadline: January 15; Final deadline: March 1

Program Inquiries: Elizabeth Webb | 901.448.7030 |

Track Heads:

Cancer and Developmental Biology
Dr. Susan A. Miranda | 901.448.1136 |
Dr. Zhaohui Wu | 901.448.2612 |
Cell Biology and Physiology
Dr. Kaushik Parthasarathi 901.448.2682 |
Genetics, Genomics, and Informatics
Dr. Byron Jones | 901.448.2814 |
Dr. Athena Davenport | 901.448.3085 |
Microbiology, Immunology, and Biochemistry
Dr. David Nelson | 901.448.8303 |
Molecular and Systems Pharmacology
Dr. Steve Tavalin | 901.448.3007 |
Dr. Fuming Zhou | 901.448.1779 |
Dr. Max Fletcher | 901.448.2212 |


Chairs, Participating Departments:

Anatomy and Neurobiology
Dr. Matthew Ennis
Genetics, Genomics, and Informatics
Dr. Robert W. Williams
Microbiology, Immunology, and Biochemistry
Dr. Michael Whitt
Dr. Mahul Amin
Dr. Alex Dopico
Dr. Zhongjie Sun
St. Jude Children's Research Hospital Liaison:
Dr. Gerard Zambetti | 901.595.6028 |


Last Published: Feb 10, 2020